Skip to main content
Rahul Tendulkar, MD, Radiation Oncology, Cleveland, OH, Cleveland Clinic

RahulDilipTendulkarMD

Radiation Oncology Cleveland, OH

Assistant Professor, Medicine, Case Western Reserve University School of Medicine

Dr. Tendulkar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tendulkar's full profile

Already have an account?

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Radiation Oncology, 2003 - 2008
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2003

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2024 - 2026
  • NY State Medical License
    NY State Medical License 2024 - 2026
  • WV State Medical License
    WV State Medical License 2024 - 2025
  • KY State Medical License
    KY State Medical License 2024 - 2025
  • OH State Medical License
    OH State Medical License 2003 - 2025
  • IN State Medical License
    IN State Medical License 2024 - 2025
  • PA State Medical License
    PA State Medical License 2024 - 2024
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features  
    Rahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Mitchel S. Anscher, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef ..., JAMA

Press Mentions

  • A Cancer No One Really Talks About
    A Cancer No One Really Talks AboutMay 1st, 2022
  • Gene Test Finds Gradations in High-Risk Prostate Cancer
    Gene Test Finds Gradations in High-Risk Prostate CancerOctober 26th, 2021
  • Ten-Year Outcomes of Moderately Hypofractionated IMRT in Prostate Cancer
    Ten-Year Outcomes of Moderately Hypofractionated IMRT in Prostate CancerOctober 22nd, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations